Severe Complications After Gastrectomy for Esophagogastric Junction and Gastric Cancer
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Gastric Cancer
Related studies linked through entity extraction aliases.
Gastric Cancer Prevention for Indigenous Peoples
- Status
- RECRUITING
- Phase
- NA
Comparing the Prognosis of Patients With Cardia and Non-cardia Gastric Cancer.
- Status
- UNKNOWN
- Phase
- N/A
The Value of TFF3 in Diagnosis of Gastric Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Phase 1 Study of LCAR-C182A Cells in the Treatment of Advanced Gastric Cancer and Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Neoadjuvant Immunotherapy for Resectable Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol in Gastric Surgery for Cancer
- Status
- UNKNOWN
- Phase
- N/A
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
The Bacterial Composition of the Stomach in Reflux Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Capecitabine or Observation for Patients With pT1N+M0 or pT2-3N0M0 Gastric Adenocarcinoma Undergoing R0 Resection
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Study About no Antimicrobial Prophylaxis in Totally Laparoscopic Distal Gastrectomy
- Status
- COMPLETED
- Phase
- NA
Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE3